Qiming U.s. Healthcare Fund Ii, L.p. - Net Worth and Insider Trading
Qiming U.s. Healthcare Fund Ii, L.p. Net Worth
The estimated net worth of Qiming U.s. Healthcare Fund Ii, L.p. is at least $75 Million dollars as of 2024-06-09. Qiming U.s. Healthcare Fund Ii, L.p. is the of Icosavax Inc and owns about 3,523,561 shares of Icosavax Inc (ICVX) stock worth over $54 Million. Qiming U.s. Healthcare Fund Ii, L.p. is also the 10% Owner of Jasper Therapeutics Inc and owns about 851,965 shares of Jasper Therapeutics Inc (JSPR) stock worth over $21 Million. Details can be seen in Qiming U.s. Healthcare Fund Ii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Qiming U.s. Healthcare Fund Ii, L.p. has not made any transactions after 2023-01-27 and currently still holds the listed stock(s).
Transaction Summary of Qiming U.s. Healthcare Fund Ii, L.p.
Qiming U.s. Healthcare Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Qiming U.s. Healthcare Fund Ii, L.p. owns 3 companies in total, including Elevation Oncology Inc (ELEV) , Icosavax Inc (ICVX) , and Jasper Therapeutics Inc (JSPR) .
Insider Ownership Summary of Qiming U.s. Healthcare Fund Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELEV | Elevation Oncology Inc | 2021-06-24 | 10 percent owner |
| ICVX | Icosavax Inc | 2021-08-02 | director & 10 percent owner |
| JSPR | Jasper Therapeutics Inc | 2023-01-27 | 10 percent owner |
Qiming U.s. Healthcare Fund Ii, L.p. Latest Holdings Summary
Qiming U.s. Healthcare Fund Ii, L.p. currently owns a total of 2 stocks. Among these stocks, Qiming U.s. Healthcare Fund Ii, L.p. owns 3,523,561 shares of Icosavax Inc (ICVX) as of August 2, 2021, with a value of $54 Million and a weighting of 72.09%. Qiming U.s. Healthcare Fund Ii, L.p. also owns 851,965 shares of Jasper Therapeutics Inc (JSPR) as of January 27, 2023, with a value of $21 Million and a weighting of 27.91%.
Latest Holdings of Qiming U.s. Healthcare Fund Ii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ICVX | Icosavax Inc | 2021-08-02 | 3,523,561 | 15.31 | 53,945,719 |
| JSPR | Jasper Therapeutics Inc | 2023-01-27 | 851,965 | 24.52 | 20,890,182 |
Holding Weightings of Qiming U.s. Healthcare Fund Ii, L.p.
Qiming U.s. Healthcare Fund Ii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Qiming U.s. Healthcare Fund Ii, L.p. has made a total of 1 transactions in Icosavax Inc (ICVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Icosavax Inc is the acquisition of 221,351 shares on August 2, 2021, which cost Qiming U.s. Healthcare Fund Ii, L.p. around $3 Million.
According to the SEC Form 4 filings, Qiming U.s. Healthcare Fund Ii, L.p. has made a total of 1 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Jasper Therapeutics Inc is the acquisition of 266,667 shares on January 27, 2023, which cost Qiming U.s. Healthcare Fund Ii, L.p. around $4 Million.
Insider Trading History of Qiming U.s. Healthcare Fund Ii, L.p.
- 1
Qiming U.s. Healthcare Fund Ii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Qiming U.s. Healthcare Fund Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Qiming U.s. Healthcare Fund Ii, L.p. is 3.06%. GuruFocus also compares Qiming U.s. Healthcare Fund Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Qiming U.s. Healthcare Fund Ii, L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Qiming U.s. Healthcare Fund Ii, L.p.'s insider trading performs compared to the benchmark.
Performance of Qiming U.s. Healthcare Fund Ii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.47 | | | | | |
| Relative Return to S&P 500(%) | 30.85 | | | | | |
Qiming U.s. Healthcare Fund Ii, L.p. Ownership Network
Qiming U.s. Healthcare Fund Ii, L.p. Owned Company Details
What does Elevation Oncology Inc do?
Who are the key executives at Elevation Oncology Inc?
Qiming U.s. Healthcare Fund Ii, L.p. is the 10 percent owner of Elevation Oncology Inc. Other key executives at Elevation Oncology Inc include CHIEF FINANCIAL OFFICER Tammy Furlong , 10 percent owner Robert J Adelman , and 10 percent owner Venbio Global Strategic Gp Iii, L.p. .
Elevation Oncology Inc (ELEV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elevation Oncology Inc Insider Transactions
Qiming U.s. Healthcare Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Qiming U.s. Healthcare Fund Ii, L.p.. You might contact Qiming U.s. Healthcare Fund Ii, L.p. via mailing address: 350 106th Avenue Ne, 1st Floor, Bellevue Wa 98004.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
